Christoph Korpus
Company: Byondis
Job title: Chief Business Officer
Seminars:
Delivering a New Generation of Antibody-Drug Conjugates & Antibody Cancer Therapeutics 3:30 pm
Advancing clinical stage assets against validated cancer targets and promising preclinical pipeline Delivering diversity, selectivity and novel mechanisms of action Averaging unique fully integrated, in-house discovery, development and manufacturingRead more
day: Day One P3